PubMed:32264791 / 1492-1685 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-OGER-BB

    {"project":"LitCovid-OGER-BB","denotations":[{"id":"T7994","span":{"begin":12,"end":16},"obj":"G_3;PG_10"},{"id":"T7995","span":{"begin":35,"end":39},"obj":"G_3;PG_10"},{"id":"T7996","span":{"begin":66,"end":83},"obj":"CHEBI:48561"},{"id":"T7997","span":{"begin":92,"end":96},"obj":"G_3;PG_10"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS."}

    LitCovid_AGAC

    {"project":"LitCovid_AGAC","denotations":[{"id":"p125242s10","span":{"begin":92,"end":103},"obj":"MPA"}],"text":"Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS."}

    Inflammaging

    {"project":"Inflammaging","denotations":[{"id":"T9","span":{"begin":0,"end":193},"obj":"Sentence"},{"id":"T9","span":{"begin":0,"end":193},"obj":"Sentence"}],"text":"Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS."}

    PubMed_ArguminSci

    {"project":"PubMed_ArguminSci","denotations":[{"id":"T8","span":{"begin":0,"end":193},"obj":"DRI_Outcome"}],"text":"Recombinant ACE2, gene-delivery of Ace2, Ang 1-7 analogs, and Mas receptor agonists enhance ACE2 action and serve as potential therapies for disease conditions associated with an activated RAS."}